BLOCKADE BY TETANUS AND BOTULINUM A TOXIN OF POSTGANGLIONIC CHOLINERGIC NERVE ENDINGS IN THE MYENTERIC PLEXUSBIGALKE H; HABERMANN E.1980; ARCH. (NANNYN-SCHMIEDEBERG'S) PHARMACOL.; DEU; DA. 1980; VOL. 312; NO 3; PP. 255-263; BIBL. 2 P.Article

Zur Struktur regulärer Parkettierungen der euklidischen Ebene = Contribution à l'étude de structures de pavages réguliers du plan euclidien = About structure of regular tilings of the Euclidian planeBIGALKE, H.-G.Zeitschrift für Kristallographie. 1986, Vol 176, Num 1-2, pp 35-65, issn 0044-2968Article

TETANUS TOXIN AND BOTULINUM A TOXIN INHIBIT ACETYL-CHOLINE RELEASE FROM BUT NOT CALCIUM UPTAKE INTO BRAIN TISSUEBIGALKE H; AHNERT HILGER G; HABERMANN E et al.1981; NAUNYN-SCHMIEDEBERG ARCH. PHARMACOL.; ISSN 0369-5565; DEU; DA. 1981; VOL. 316; NO 2; PP. 143-148; BIBL. 28 REF.Article

TETANUS TOXIN BLOCKS THE NEUROMUSCULAR TRANSMISSION IN VITRO LIKE BOTULINUM A TOXINHABERMANN E; DREYER F; BIGALKE H et al.1980; ARCH. (NAUNYN-SCHMIEDEBERG'S) PHARMACOL.; DEU; DA. 1980; VOL. 311; NO 1; PP. 33-40; BIBL. 34 REF.Article

INHIBITION OF SYNAPTOSOMAL CHOLINE UPTAKE BY TETRANUS AND BOTULINUM A TOXIN: PARTIAL DISSOCIATION OF FIXATION AND EFFECT OF TETANUS TOXINHABERMANN E; BIGALKE H; HELLER I et al.1981; NAUNYN-SCHMIEDEBERG ARCH. PHARMACOL.; ISSN 0369-5565; DEU; DA. 1981; VOL. 316; NO 2; PP. 135-142; BIBL. 29 REF.Article

SUPPRESSION OF ³H-ACETYLCHOLINE RELEASE FROM PRIMARY NERVE CELL CULTURES BY TETANUS AND BOTULINUM - A TOXIN.BIGALKE H; DIMPFEL W; HABERMANN E et al.1978; ARCH. (NAUNYN-SCHMIEDEBERG'S)PHARMACOL.; DEU; DA. 1978; VOL. 303; NO 2; PP. 133-138; BIBL. 36 REF.Article

Restoration of exocytosis occurs after inactivation of intracellular tetanus toxinBARTELS, F; BIGALKE, H.Infection and immunity. 1992, Vol 60, Num 1, pp 302-307, issn 0019-9567Article

Microelectrode measurement of cell membrane potential in isolated hepatocytes attached to collagenPETZINGER, E; BIGALKE, H.Biochimica et biophysica acta. 1986, Vol 863, Num 2, pp 318-324, issn 0006-3002Article

The translocation of botulinum a neurotoxin by chromaffin cells is promoted in low ionic strength solution and is insensitive to trypsinMARXEN, P; ERDMANN, G; BIGALKE, H et al.Toxicon (Oxford). 1991, Vol 29, Num 2, pp 181-189, issn 0041-0101, 9 p.Article

Differential effects of tetanus toxin on inhibitory and excitatory synaptic transmission in mammalian spinal cord neurons in culture: a presynaptic locus of action for tetanus toxinBERGEY, G. K; BIGALKE, H; NELSON, P. G et al.Journal of neurophysiology. 1987, Vol 57, Num 1, pp 121-131, issn 0022-3077Article

Clostridial neurotoxinsBIGALKE, H; SHOER, L. F.Handbook of experimental pharmacology. 2000, Vol 145, pp 407-443, issn 0171-2004Article

Botulinum toxin antibody testing : Comparison between the mouse protection assay and the mouse lethality assayDRESSIER, D; DIRNBERGER, G; BHATIA, K. P et al.Movement disorders. 2000, Vol 15, Num 5, pp 973-976, issn 0885-3185Article

Uptake of antitetanus F(ab')₂ fragments into eukaryotic cellsWELLHOÊNER, H. H; BIGALKE, H; BORCHOLTE, T et al.Journal de physiologie (Paris). 1990, Vol 84, Num 3, pp 206-210, issn 0021-7948, 5 p.Article

Botulinum A neurotoxin unlike tetanus toxin acts via a neuraminidase sensitive structureBIGALKE, H; MÜLLER, H; DREYER, F et al.Toxicon (Oxford). 1986, Vol 24, Num 11-12, pp 1065-1074, issn 0041-0101Article

Botulinum A neurotoxin inhibits non-cholinergic synaptic transmission in mouse spinal cord neurons in cultureBIGALKE, H; DREYER, F; BERGEY, G et al.Brain research. 1985, Vol 360, Num 1-2, pp 318-324, issn 0006-8993Article

Treatment of habitual snoring with botulinum toxin : a pilot studyKÜHNEL, T. S; SCHULTE-MATTLER, W; BIGALKE, H et al.Sleep & breathing. 2008, Vol 12, Num 1, pp 63-68, issn 1520-9512, 6 p.Article

Tetanus antitoxin binds to intracellular tetanus toxin in permeabilized chromaffin cells without restoring Ca²⁺-induced exocytosisMARXEN, P; AHNERT-HILGER, G; WELLHOÊNER, H. H et al.Toxicon (Oxford). 1990, Vol 28, Num 9, pp 1077-1082, issn 0041-0101, 6 p.Article

Differential effects of various secretagogues on quantal transmitter release from mouse motor nerve terminals treated with botulinum A and tetanus toxinDREYER, F; ROSENBERG, F; BECKER, C et al.Naunyn-Schmiedeberg's archives of pharmacology. 1987, Vol 335, Num 1, pp 1-7, issn 0028-1298Article

Action of botilinum A toxin and tetanus on synaptic transmissionDREYER, F; BECKER, C; BIGALKE, H et al.Journal de physiologie (Paris). 1984, Vol 79, Num 4, pp 252-258, issn 0021-7948Article

The sternocleidomastoid test: an in vivo assay to investigate botulinum toxin antibody formation in humansDRESSIER, D; BIGALKE, H; ROTHWELL, J. C et al.Journal of neurology. 2000, Vol 247, Num 8, pp 630-632, issn 0340-5354Article

Secondary non-response due to development of neutralising antibodies to botulinum toxin A during treatment of children with cerebral palsyHERRMANN, J; MALL, V; BIGALKE, H et al.Neuropediatrics. 2000, Vol 31, Num 6, pp 333-334, issn 0174-304XArticle

Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label studyROLLNIK, J. D; MATZKE, M; WOHLFARTH, K et al.European neurology. 2000, Vol 43, Num 1, pp 9-12, issn 0014-3022Article

Depletion of neutralising antibodies resensitises a secondary non-responder to botulinum A neurotoxinNAUMANN, M; TOYKA, K. V; TALEGHANI, B. M et al.Journal of neurology, neurosurgery and psychiatry. 1998, Vol 65, Num 6, pp 924-927, issn 0022-3050Article

Botulinum A toxin therapy : Neutralizing and nonneutralizing antibodies-therapeutic consequencesGÖSCHEL, H; WOHLFARTH, K; FREVERT, J et al.Experimental neurology (Print). 1997, Vol 147, Num 1, pp 96-102, issn 0014-4886Article

Distinct targets for tetanus and botulinum A neurotoxins within the signal transducing pathway in chromaffin cellsMARXEN, P; BARTELS, F; AHNERT-HILGER, G et al.Naunyn-Schmiedeberg's archives of pharmacology. 1991, Vol 344, Num 4, pp 387-395, issn 0028-1298Article